Lawrence Lum is an Oncology physician affiliated with University of Virginia Cancer Center. OpenAlex indexes 491 publications with 7,827 citations (h-index 44); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4100 John R
Karmanos Cancer Center
Detroit, MI 482012013
Telephone
800-527-6266Registry record last updated 24 Jan 2014.
Clinical trials
- Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
Sponsor: University of Virginia
- Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor: Barbara Ann Karmanos Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ironwood Pharmaceuticals, IncProgram year20231 payment
- Siemens Medical Solutions USA, Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2006–2015 per NIH RePORTER. The latest:
- Enhancing neoadjuvant chemotherpay responses with targeted T cells
Wayne State University
FY2014$1R01CA140314
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release
Journal for ImmunoTherapy of Cancer
2021 - Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma
Journal of Controlled Release
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Showalter, MD
University of Virginia Cancer Center
Shayna Showalter, MD
University of Virginia Cancer Center
Michael Keng, MD
University of Virginia Cancer Center
Christiana Brenin, MD
University of Virginia Cancer Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”